Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Unresectable · Locally Advanced or Metastatic Solid Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shandong Cancer Hospital & Institute, Jinan, Shandong, China
Contact: Study coordinator (Jinming Yu) · sdyujinming@126.com · 13806406293
Contact: Study coordinator (Yuping Sun) · 13370582181@126.com · 13370582181
Contact: Principal Investigator (Jinming Yu, M.D.)
Contact: Principal Investigator (Yuping Sun, M.D.)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

Unresectable · Locally Advanced · Metastatic Cancers

Abroad (travel likely)RecruitingPHASE1, PHASE2

Duarte, United States · Cleveland, United States

A Beta-only IL-2 ImmunoTherapY Study

Advanced Solid Tumor · Unresectable Solid Tumor · Clear Cell Renal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Diego, United States · San Francisco, United States

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Solid Tumor · Non-Small-Cell Lung Cancer · Pancreatic Ductal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1

Santa Monica, United States · Atlanta, United States

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Anatomic Stage IV Breast Cancer AJCC v8 · Clinical Stage IV Cutaneous Melanoma AJCC v8 · Locally Advanced Cutaneous Melanoma

Abroad (travel likely)RecruitingPHASE1

Seattle, United States